相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa
Jason M. Pogue et al.
CLINICAL INFECTIOUS DISEASES (2020)
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
Johann Motsch et al.
CLINICAL INFECTIOUS DISEASES (2020)
Colistin for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
Jun-Yuan Zheng et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Clinical and subclinical acute kidney injury in multidrug-resistant septic patients treated with colistimethate sodium: Incidence and clinical outcomes
Theerachai Thammathiwat et al.
NEPHROLOGY (2020)
Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis
Hsiu-Ting Chien et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
A Comparison of Adjusted Versus Unadjusted Doses of Polymyxin B Based on Renal Function and Incidence of Acute Kidney Injury
Vincent Peyko et al.
JOURNAL OF PHARMACY PRACTICE (2020)
Efficacy and Safety of High Loading Dose of Colistin in Multidrug-Resistant Acinetobacter baumannii: A Prospective Cohort Study
Wasan Katip et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2019)
Colistin Use in Patients with Extreme Renal Function: From Dialysis to Augmented Clearance
Aleksandra Aitullina et al.
MEDICINA-LITHUANIA (2019)
Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?
Luisa Sorli et al.
MOLECULES (2019)
Molecular Mechanisms of Colistin-Induced Nephrotoxicity
Zhibo Gai et al.
MOLECULES (2019)
Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae
James A. McKinnell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
International Consensus Guidelines for the Optimal Use of the Polymyxins Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
Brian T. Tsuji et al.
PHARMACOTHERAPY (2019)
Incidence of Acute Kidney Injury in Intermittent Versus Continuous Infusion of Polymyxin B in Hospitalized Patients
Yarelis Alvarado Reyes et al.
ANNALS OF PHARMACOTHERAPY (2019)
Intravenous colistin use for infections due to MDR Gram-negative bacilli in critically ill paediatric patients: a systematic review and meta-analysis
Spyridon A. Karageorgos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Adjunctive therapy of intravenous colistin to intravenous tigecycline for adult patients with non-bacteremic post-surgical intra-abdominal infection due to carbapenem-resistant Acinetobacter baumannii
Sarunyou Chusri et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2019)
Clinical and Microbiological Outcomes in Obese Patients Receiving Colistin for Carbapenem-Resistant Gram-Negative Bloodstream Infection
Simon W. Lam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia
Adela Benitez-Cano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
The Use of Colistin for the Treatment of Multidrug-resistant Gram-negative Infections in Neonates and Infants A Review of the Literature
Narongsak Nakwan et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2019)
Clinical Outcomes Of Colistin In Combination With Either 6-G Sulbactam Or Carbapenems For The Treatment Of Extensively Drug-Resistant Acinetobacter Baumannii Pneumonia With High MIC To Sulbactam, A Prospective Cohort Study
Chutchawan Ungthammakhun et al.
INFECTION AND DRUG RESISTANCE (2019)
Impact of an Acinetobacter baumannii outbreak on kidney events in a burn unit: A targeted machine learning analysis
Thomas Vauchel et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2019)
2262. Ceftazidime–Avibactam vs. Polymyxin B in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
Jamie John et al.
Open Forum Infectious Diseases (2019)
Nephrotoxicity prevalence in patients treated with polymyxins: a systematic review with meta-analysis of observational studies
Ana F. Oliota et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)
Safety and efficacy of colistin alone or in combination in adults with Acinetobacter baumannii infection: A systematic review and meta-analysis
Jin Wang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Polymyxin B clinical outcomes: A prospective study of patients undergoing intravenous treatment
Karen P. H. Mattos et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
Eun Jung Kim et al.
THERAPEUTIC DRUG MONITORING (2019)
Colistin and polymyxin B for treatment of nosocomial infections in intensive care unit patients: pharmacoeconomic analysis
Julia Coelho Franca Quintanilha et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2019)
Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria
Junsu Choe et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2019)
Treatment of ventilator-associated pneumonia with high-dose colistin under continuous veno-venous hemofiltration
Herbert Spapen et al.
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE (2019)
Retrospective Study of Nephrotoxicity Rate among Adult Patients Receiving Colistin Compared to β-lactam Antibiotics
Abdul Ghafur et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2019)
Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity
Roger L. Nation et al.
ANTIBIOTICS-BASEL (2019)
Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial
Jose M. Cisneros et al.
CRITICAL CARE (2019)
Can Nebulised Colistin Therapy Improve Outcomes in Critically Ill Children with Multi-Drug Resistant Gram-Negative Bacterial Pneumonia?
Fatih Aygun et al.
ANTIBIOTICS-BASEL (2019)
Nephrotoxicity Associated with Intravenous Polymyxin B Once- versus Twice-Daily Dosing Regimen
Adeola Okoduwa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis
Cely Saad Abboud et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2018)
Attributable Risk and Time Course of Colistin-Associated Acute Kidney Injury
Todd A. Miano et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Chronic kidney disease after acute kidney injury associated with intravenous colistin use in survivors of severe infections: A comparative cohort study
Alejandro Meraz-Munoz et al.
JOURNAL OF CRITICAL CARE (2018)
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
Mical Paul et al.
LANCET INFECTIOUS DISEASES (2018)
Incidence and risk factors of nephrotoxicity in patients on colistimethate sodium
Moataz M. Hassan et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2018)
Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study
Ritesh Aggarwal et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2018)
Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
Shio-Shin Jean et al.
MEDICINE (2018)
Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia
Abdul Karim Suleman Cara et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2018)
Efficacy and Safety of Intravenous Colistin in Very Low Birth Weight Preterm Infants
Ozkan Ilhan et al.
PEDIATRIC DRUGS (2018)
Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia
Hossein Khalili et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2018)
Effectiveness and safety of polymyxin B for the treatment of infections caused by extensively drug-resistant Gram-negative bacteria in Thailand
Thundon Ngamprasertchai et al.
INFECTION AND DRUG RESISTANCE (2018)
The Impact of Acute Kidney Injury on the Risk of Mortality and Health Care Utilization Among Patients Treated With Polymyxins for Severe Gram-Negative Infections
Sarah Baradaran et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Risk factors of colistin safety according to administration routes: Intravenous and aerosolized colistin
Kyoung Lok Min et al.
PLOS ONE (2018)
Prospective, comparative clinical study between high-dose colistin monotherapy and colistin-meropenem combination therapy for treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae
Mohamed Farouk Ahmed Abdelsalam et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2018)
Colistin nephrotoxicity in the ICU: Is it different in the geriatric patients?
Burcu Basarik Aydogan et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2018)
Monitoring therapeutic colistin concentrations in critically ill patients admitted to a tertiary care hospital
Sriramulu Manivannan Vithunes et al.
DRUGS & THERAPY PERSPECTIVES (2018)
Colistin versus Colistin Combined with Ampicillin-Sulbactam for Multiresistant Acinetobacter baumannii Ventilator-associated Pneumonia Treatment: An Open-label Prospective Study
Demosthenes Makris et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2018)
Severe Infusion-Related Adverse Events and Renal Failure in Patients Receiving High-Dose Intravenous Polymyxin B
Josiane F. John et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
A Retrospective Cohort Analysis Shows that Coadministration of Minocycline with Colistin in Critically Ill Patients Is Associated with Reduced Frequency of Acute Renal Failure
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Neutrophil Gelatinase-associated Lipocalin as a Predictor of Acute Kidney Injury in Patients during Treatment with Colistimethate Sodium
So Yeon Park et al.
INFECTION AND CHEMOTHERAPY (2018)
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
Alexandre P. Zavascki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Efficacy and Safety of a Colistin Loading Dose, High-Dose Maintenance Regimen in Critically Ill Patients With Multidrug-Resistant Gram-Negative Pneumonia
Jessica L. Elefritz et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2017)
Good tolerability of high dose colistin-based therapy in patients with haematological malignancies
Sara Grignolo et al.
INFECTION (2017)
Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii
Ji Young Jang et al.
JOURNAL OF CRITICAL CARE (2017)
Colistin use in critically ill neonates: A case-control study
Mehmet Sah Ipek et al.
PEDIATRICS AND NEONATOLOGY (2017)
Risk factors for colistin-associated nephrotoxicity and mortality in critically ill patients
Huseyin Ozkarakas et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2017)
Fluid overload is an independent risk factor for acute kidney injury in critically III patients: results of a cohort study
Nawal Salahuddin et al.
BMC NEPHROLOGY (2017)
Colistin-induced nephrotoxicity and the role of N-acetylcysteine: a retrospective cohort study
Ilkay Bozkurt et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2017)
Polymyxin-B and vancomycin-associated acute kidney injury in critically ill patients
Douglas de Sousa Soares et al.
PATHOGENS AND GLOBAL HEALTH (2017)
Efficacy of nebulized colistin-based therapy without concurrent intravenous colistin for ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii
Yong Kyun Kim et al.
JOURNAL OF THORACIC DISEASE (2017)
Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients
Wasan Katip et al.
INFECTION AND DRUG RESISTANCE (2017)
Factors Determining Nephrotoxicity and Mortality in Critical Care Patients Receiving Colistin
Ali Ciftci et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2017)
Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria
Ryan K. Shields et al.
PLOS ONE (2017)
Aerosolized colistin in the treatment of multiresistant Pseudomonas aeruginosa nosocomial pneumonia
Boubaker Charra et al.
Signa Vitae (2017)
Evaluation of nephrotoxicity and prognosis in patients treated with colistin due to hospital-acquired pneumonia
Pervin Korkmaz Ekren et al.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX (2017)
Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill Patients
Alan Forrest et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Outcome analysis of colistin-treated burn center patients
Rachel E. Wilkinson et al.
BURNS (2017)
Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections
Sonia Luque et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Colistin Nephrotoxicity in Adults: Single Centre Large Series from India
Abdul Ghafur et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2017)
Nephrotoxicity in Patients with or without Cystic Fibrosis Treated with Polymyxin B Compared to Colistin
Ryan L. Crass et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Clinical considerations for optimal use of the polymyxins: A focus on agent selection and dosing
J. M. Pogue et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa
Luisa Sorli et al.
BMC INFECTIOUS DISEASES (2017)
Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli
Gabrielle A. Gibson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Variables determining the development of colistin-associated renal impairment
Bahadir Ceylan et al.
WIENER KLINISCHE WOCHENSCHRIFT (2016)
Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin
George Fotakopoulos et al.
ACTA NEUROCHIRURGICA (2016)
Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam
Ronen Zalts et al.
AMERICAN JOURNAL OF THERAPEUTICS (2016)
Clinical Efficacy of Polymyxin Monotherapy versus Nonvalidated Polymyxin Combination Therapy versus Validated Polymyxin Combination Therapy in Extensively Drug-Resistant Gram-Negative Bacillus Infections
Bingxuan Cai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B
Maria Helena Rigatto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study
Yael Dishon Benattar et al.
CLINICAL INFECTIOUS DISEASES (2016)
Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections
E. Durante-Mangoni et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Is colistin effective in the treatment of infections caused by multidrug-resistant (MDR) or extremely drug-resistant (XDR) gram-negative microorganisms in children?
Yasemin Ozsurekci et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)
An audit of colistin use in neonatal sepsis from a tertiary care centre of a resource-limited country
Bonny Jasani et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2016)
Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate
Juan P. Horcajada et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Ten years with colistin: a retrospective case series
D. E. Katz et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2016)
Risk Factors for Colistin-Associated Acute Kidney Injury: A Multicenter Study from Turkey
Serdar Gul et al.
JAPANESE JOURNAL OF INFECTIOUS DISEASES (2016)
Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study
Kady Phe et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Role of aerosolized colistin methanesulfonate therapy for extensively-drug-resistant Acinetobacter baumannii complex pneumonia and airway colonization
Tai-Chin Hsieh et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
Clinical Characteristics of Carbapenem-resistant Klebsiella pneumoniae Infections in Ill and Colonized Children in Colombia
Alejandro Diaz et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2016)
Colistin, an Old Drug in a New Territory, Solid Organ Transplantation
D. F. Florescu et al.
TRANSPLANTATION PROCEEDINGS (2016)
Colistin efficacy in the treatment of multidrug-resistant and extremely drug-resistant gram-negative bacterial infections
Cigdem Banu Cetin et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2016)
Intravenous Colistin in the treatment of multidrug-resistant Acinetobacter in neonates
Manar Al-Lawama et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2016)
Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
Tuna Demirdal et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2016)
Intravenous Colistin Use for Multidrug-Resistant Gram-Negative Infections in Pediatric Patients
Ayse Karaaslan et al.
BALKAN MEDICAL JOURNAL (2016)
Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial
Sami Abdellatif et al.
ANNALS OF INTENSIVE CARE (2016)
Clinical outcomes and safety of colistin in treatment of gram negative infections: A prospective observational study
Kinnari Desai et al.
EGYPTIAN JOURNAL OF CRITICAL CARE MEDICINE (2016)
Comparison of clinical characteristics of patients with acute kidney injury after intravenous versus inhaled colistin therapy
A. Young Cho et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2016)
The risk factors of colistin methanesulfonate associated nephrotoxicity
Elif Tukenmez Tigen et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2016)
Clinical Outcomes Associated with Polymyxin B Dose in Patients with Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Rods
Brian C. Nelson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Preliminary Clinical Study of the Effect of Ascorbic Acid on Colistin-Associated Nephrotoxicity
Rujipas Sirijatuphat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients
Ilias Karaiskos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study
Lidia Dalfino et al.
CLINICAL INFECTIOUS DISEASES (2015)
Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study
Aristine Cheng et al.
CRITICAL CARE MEDICINE (2015)
Association Between Colistin Dose and Development of Nephrotoxicity
Yu-Ji Lee et al.
CRITICAL CARE MEDICINE (2015)
A review on colistin nephrotoxicity
Atefeh Ordooei Javan et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Safety and Efficacy of Intravenous Colistin in Children
Poddutoor Preetham Kumar et al.
INDIAN PEDIATRICS (2015)
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study
Eric A. J. Hoste et al.
INTENSIVE CARE MEDICINE (2015)
Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes
Ki Hwan Kwon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
The efficacy and nephrotoxicity associated with colistin use in an intensive care unit in Vietnam: Use of colistin in a population of lower body weight
Nguyen Gia Binh et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Incidence and Risk Factors for Colistin-Associated Nephrotoxicity
Fatih Temocin et al.
JAPANESE JOURNAL OF INFECTIOUS DISEASES (2015)
Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study
Maria Helena Rigatto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Risk factors for nephrotoxicity onset associated with polymyxin B therapy
Yanina Dubrovskaya et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia
Gul Ruhsar Yilmaz et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2015)
Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children
Meltem Polat et al.
PEDIATRIC DRUGS (2015)
Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection
Zhijin Chen et al.
SCIENTIFIC REPORTS (2015)
High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia
Ali S. Omrani et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2015)
High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baummannii in critically ill cancer patients: a retrospective cohort study
Lama H. Nazer et al.
INFECTIOUS DISEASES (2015)
Efficacy and Toxicity of High-Dose Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections: A Comparative Study of a Matched Series
Ahlem Trifi et al.
CHEMOTHERAPY (2015)
Efficacy and Safety of Intravenous Colistin in Preterm Infants with Nosocomial Sepsis Caused by Acinetobacter baumannii
Serdar Alan et al.
AMERICAN JOURNAL OF PERINATOLOGY (2014)
Clinical Experience of Colistin-Glycopeptide Combination in Critically Ill Patients Infected with Gram-Negative Bacteria
Nicola Petrosillo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In Vitro Assessment and Multicenter Cohort Study of Comparative Nephrotoxicity Rates Associated with Colistimethate versus Polymyxin B Therapy
Kady Phe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
Rujipas Sirijatuphat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
New Colistin Population Pharmacokinetic Data in Critically Ill Patients Suggesting an Alternative Loading Dose Rationale
N. Gregoire et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
A retrospective study on the effects of colistin therapy in children with multidrug-resistant Gram-negative bacterial pathogens: impact of HIV status on outcome
Konstantinos Dimitriades et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2014)
Efficacy and Safety Profile Comparison of Colistin and Tigecycline on the Extensively Drug Resistant Acinetobacter baumannii
Sung Hee Kwon et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2014)
Multi-drug resistant gram negative infections and use of intravenous polymyxin B in critically ill children of developing country: retrospective cohort study
Naveed-ur-Rehman Siddiqui et al.
BMC INFECTIOUS DISEASES (2014)
Effectiveness of tigecycline-based versus colistin-based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis
Yu-Chung Chuang et al.
BMC INFECTIOUS DISEASES (2014)
Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections
A. Batirel et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
G. Kalin et al.
INFECTION (2014)
Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: A systematic review and meta-analysis
Wan-Jie Gua et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia
Thana Khawcharoenporn et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium
Felipe F. Tuon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria
S. T. R. Zaidi et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
The Use of Colistin in Critically Ill Children in a Pediatric Intensive Care Unit
Adem Karbuz et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy
Robbert Crusio et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2014)
Colistin nephrotoxicity increases with age
Ilker Inanc Balkan et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2014)
Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii
Hee Kyoung Choi et al.
YONSEI MEDICAL JOURNAL (2014)
Evaluation of risk of nephrotoxicity with high dose, extended-interval colistin administration
Arun Dewan et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2014)
Risk Factors for Treatment Failure of Polymyxin B Monotherapy for Carbapenem-Resistant Klebsiella pneumoniae Infections
Yanina Dubrovskaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Nephrotoxicity and Efficacy Assessment of Polymyxin Use in 92 Transplant Patients
Marcelo M. Mostardeiro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study
Luisa Sorli et al.
BMC INFECTIOUS DISEASES (2013)
Clinical Efficacy and Safety of the Combination of Colistin plus Vancomycin for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
Jose Garnacho-Montero et al.
CHEMOTHERAPY (2013)
Effect of Aerosolized Colistin as Adjunctive Treatment on the Outcomes of Microbiologically Documented Ventilator-Associated Pneumonia Caused by Colistin-Only Susceptible Gram-Negative Bacteria
Mario Tumbarello et al.
CHEST (2013)
Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia
Giulia Vicari et al.
CLINICAL INFECTIOUS DISEASES (2013)
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
Emanuele Durante-Mangoni et al.
CLINICAL INFECTIOUS DISEASES (2013)
Higher Incidence of Acute Kidney Injury With Intravenous Colistimethate Sodium Compared With Polymyxin B in Critically Ill Patients at a Tertiary Care Medical Center
Darowan S. Akajagbor et al.
CLINICAL INFECTIOUS DISEASES (2013)
Urinary neutrophil gelatinase-associated lipocalin for early detection of acute kidney injury in geriatric patients with urinary tract infection treated by colistin
Linda Shavit et al.
CLINICAL NEPHROLOGY (2013)
Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection
Niteen D. Karnik et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Parenteral polymyxins: Assessing efficacy and safety in critically ill patients with renal dysfunction
Kavita Sekhri et al.
INDIAN JOURNAL OF PHARMACOLOGY (2013)
Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patients
D. Averbuch et al.
INFECTION (2013)
Impact of the initiation time of colistin treatment for Acinetobacter infections
Elif Tukenmez Tigen et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Clinical and microbiological efficacy and toxicity of colistin in patients infected with multidrug-resistant gram-negative pathogens
Gul R. Yilmaz et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
Intravenous Colistin for Multidrug-Resistant Gram-Negative Infections in Critically Ill Pediatric Patients
Kapil Kapoor et al.
PEDIATRIC CRITICAL CARE MEDICINE (2013)
The Use of Intravenous Colistin Among Children in the United States: Results From a Multicenter, Case Series
Pranita D. Tamma et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Emergent Renal Dysfunction with Colistin Pharmacotherapy
Julie M. Collins et al.
PHARMACOTHERAPY (2013)
Evaluation of colistin nephrotoxicity administered at different doses in the rat model
Zohra Ghlissi et al.
RENAL FAILURE (2013)
Colistin use in pediatric intensive care unit for severe nosocomial infections: experience of an university hospital
Arzu Karli et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2013)
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study
Monica Rocco et al.
CRITICAL CARE (2013)
To study the clinical efficacy and nephrotoxicity along with the risk factors for acute kidney injury associated with parenteral polymyxin B
Ruchika Nandha et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2013)
Colistin effectiveness and nephrotoxicity: experience from a tertiary care burns unit in Oman
Said Al-Busaidi et al.
EUROPEAN JOURNAL OF PLASTIC SURGERY (2013)
Incidence and Predictors of Nephrotoxicity Associated with Intravenous Colistin in Overweight and Obese Patients
Timothy P. Gauthier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
High-Dose, Extended-Interval Colistin Administration in Critically Ill Patients: Is This the Right Dosing Strategy? A Preliminary Study
Lidia Dalfino et al.
CLINICAL INFECTIOUS DISEASES (2012)
Colistin therapy in critically ill patients with chronic renal failure and its effect on development of renal dysfunction
Melda Turkoglu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Old agent, new experience: colistin use in the paediatric Intensive Care Unit-a multicentre study
Muhammet Sukru Paksu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?
Gamze Kalin et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
A retrospective observational study on the efficacy of colistin by inhalation as compared to parenteral administration for the treatment of nosocomial pneumonia associated with multidrug-resistant Pseudomonas aeruginosa
Reinout Naesens et al.
BMC INFECTIOUS DISEASES (2011)
Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
Jason M. Pogue et al.
CLINICAL INFECTIOUS DISEASES (2011)
Efficacy and Safety of Colistin in the Treatment of Infections Caused by Multidrug-resistant Pseudomonas aeruginosa in Patients with Hematologic Malignancy: A Matched Pair Analysis
Nadira Durakovic et al.
INTERNAL MEDICINE (2011)
Polymyxin B versus other antimicrobials for the treatment of Pseudomonas aeruginosa bacteraemia
Carlos H. Kvitko et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
The Outcomes of Using Colistin for Treating Multidrug Resistant Acinetobacter Species Bloodstream Infections
Seung-Kwan Lim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2011)
Early Acute Kidney Injury Is a Risk Factor That Predicts Mortality in Patients Treated with Colistin
Hee ja Ko et al.
NEPHRON CLINICAL PRACTICE (2011)
Intravenous Colistin Administration in Neonates
Mamta Jajoo et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Nephrotoxicity Associated with Intravenous Colistin in Critically Ill Patients
Neha M Doshi et al.
PHARMACOTHERAPY (2011)
Renal and neurological side effects of colistin in critically ill patients
Herbert Spapen et al.
ANNALS OF INTENSIVE CARE (2011)
Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital
C. Andrew DeRyke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Use of colistin in treating multi-resistant Gram-negative organisms in a specialised burns unit
H. Ganapathy et al.
BURNS (2010)
Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
Roberto Imberti et al.
CHEST (2010)
Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator-Associated Pneumonia: A Matched Case-Control Study
Diamantis P. Kofteridis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Predictors of acute kidney injury associated with intravenous colistin treatment
Jeong-Ah Kwon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
Chien-Yu Cheng et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
Pinyo Rattanaumpawan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic
Laura S. Elias et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients
Solmaz Celebi et al.
PEDIATRICS INTERNATIONAL (2010)
Intravenous colistin sulfate: A rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections
Jie Huang et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2010)
Antimicrobial Treatment and Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia
Jeannie D. Chan et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2010)
Prevalence and Risk Factors for Acute Kidney Injury Associated with Parenteral Polymyxin B Use
Carlos A. C. Mendes et al.
ANNALS OF PHARMACOTHERAPY (2009)
Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections
Ronald Gounden et al.
BMC INFECTIOUS DISEASES (2009)
Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
Joshua D. Hartzell et al.
CLINICAL INFECTIOUS DISEASES (2009)
Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity
Maura S. Oliveira et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
New information about the polymyxin/colistin class of antibiotics
Jose Molina et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Effectiveness and Safety of Colistin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections
M. Montero et al.
INFECTION (2009)
Clinical characteristics and risk factors of colistin-induced nephrotoxicity
Jieun Kim et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Intravenous Colistimethate (Colistin) Use in Critically III Children Without Cystic Fibrosis
Matthew E. Falagas et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Nephrotoxicity associated with the use of intravenous colistin
Cecilia Santamaria et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2009)
Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: A retrospective case series
Andrew A. Pastewski et al.
ANNALS OF PHARMACOTHERAPY (2008)
Utilization of colistin for treatment of multidrug-resistant Pseudomonas aeruginosa
Deana M. Sabuda et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2008)
Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients
Alexandre P. Zavascki et al.
CLINICAL INFECTIOUS DISEASES (2008)
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
Nikolaos Markou et al.
CLINICAL THERAPEUTICS (2008)
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
M. S. Oliveira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Pseudomonas aeruginosa Susceptible Only to Colistin in Intensive Care Unit Patients
Aikaterini Mastoraki et al.
SURGICAL INFECTIONS (2008)
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
M. Bassetti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock
Suresh Ramasubban et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2008)
Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand
Pornpan Koomanachai et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2007)
Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
F. G. Rios et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study
H. Kallel et al.
INTENSIVE CARE MEDICINE (2007)
Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population
Jeremy Goverman et al.
JOURNAL OF BURN CARE & RESEARCH (2007)
Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit
Katherine P. Holloway et al.
ANNALS OF PHARMACOTHERAPY (2006)
Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU
Hatem Kallel et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria
M. E. Falagas et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
Nephrotoxicity of intravenous colistin: a prospective evaluation
ME Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Acute renal failure in critically ill patients - A multinational, multicenter study
S Uchino et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections:: a prospective cohort study
R Reina et al.
INTENSIVE CARE MEDICINE (2005)
Toxicity after prolonged (more than four weeks) administration of intravenous colistin
ME Falagas et al.
BMC INFECTIOUS DISEASES (2005)
Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections
ME Sobieszczyk et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Spectrum of acute renal failure in the intensive care unit: The PICARD experience
RL Mehta et al.
KIDNEY INTERNATIONAL (2004)
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
N Markou et al.
CRITICAL CARE (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria
JP Ouderkirk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin:: A comparison with imipenem-susceptible VAP
J Garnacho-Montero et al.
CLINICAL INFECTIOUS DISEASES (2003)
The pharmacokinetics of colistin in patients with cystic fibrosis
MD Reed et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
分享论文
